Jupiter Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Jupiter Asset Management's BMY Position: Q2 2026 in Review

Jupiter Asset Management increased its Bristol-Myers Squibb (BMY) stake by 3,354% in Q2 2026, buying an estimated $7.39M and bringing the position to 132,573 shares worth $7.64M. The position accounts for 0.04% of the portfolio, ranked #325.

Jupiter Asset Management first reported a position in BMY in Q2 2013 and has held it in 18 quarters since. The position peaked at $62M in Q2 2025. 2,511 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

• Jupiter Asset Management held 132,573 shares of Bristol-Myers Squibb worth $7.64M as of Q2 2026.
• Jupiter Asset Management bought 128,735 Bristol-Myers Squibb shares in Q2 2026, an estimated $7.39M.
• Bristol-Myers Squibb made up 0.04% of Jupiter Asset Management's portfolio in Q2 2026, its #325 holding.
• Jupiter Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 18 quarters since.
• Jupiter Asset Management's Bristol-Myers Squibb position peaked at $62M in Q2 2025.
• 2,511 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Jupiter Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.